Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

SARS-CoV-2 target regions

enabled by data from

Testing Method Country Host Source Number of differences Collection Date Navigate
WHO-4 Argentina Human GISAID : EPI_ISL_430799 0 30/03/20 Go to details
WHO-5 Argentina Human GISAID : EPI_ISL_430799 0 30/03/20 Go to details
WHO-6 Argentina Human GISAID : EPI_ISL_430799 0 30/03/20 Go to details
WHO-7 Argentina Human GISAID : EPI_ISL_430799 0 30/03/20 Go to details
JRC-S Argentina Human GISAID : EPI_ISL_430799 0 30/03/20 Go to details
WHO-1 Argentina Human GISAID : EPI_ISL_430800 0 30/03/20 Go to details
WHO-2 Argentina Human GISAID : EPI_ISL_430800 0 30/03/20 Go to details
WHO-3 Argentina Human GISAID : EPI_ISL_430800 0 30/03/20 Go to details
WHO-4 Argentina Human GISAID : EPI_ISL_430800 0 30/03/20 Go to details
WHO-5 Argentina Human GISAID : EPI_ISL_430800 0 30/03/20 Go to details
WHO-6 Argentina Human GISAID : EPI_ISL_430800 0 30/03/20 Go to details
WHO-7 Argentina Human GISAID : EPI_ISL_430800 0 30/03/20 Go to details
JRC-S Argentina Human GISAID : EPI_ISL_430800 0 30/03/20 Go to details
WHO-1 Argentina Human GISAID : EPI_ISL_430801 0 31/03/20 Go to details
WHO-2 Argentina Human GISAID : EPI_ISL_430801 0 31/03/20 Go to details
WHO-3 Argentina Human GISAID : EPI_ISL_430801 0 31/03/20 Go to details
WHO-4 Argentina Human GISAID : EPI_ISL_430801 0 31/03/20 Go to details
WHO-5 Argentina Human GISAID : EPI_ISL_430801 0 31/03/20 Go to details
WHO-6 Argentina Human GISAID : EPI_ISL_430801 0 31/03/20 Go to details
WHO-7 Argentina Human GISAID : EPI_ISL_430801 0 31/03/20 Go to details
JRC-S Argentina Human GISAID : EPI_ISL_430801 0 31/03/20 Go to details
WHO-1 Argentina Human GISAID : EPI_ISL_430802 0 31/03/20 Go to details
WHO-2 Argentina Human GISAID : EPI_ISL_430802 0 31/03/20 Go to details
WHO-3 Argentina Human GISAID : EPI_ISL_430802 0 31/03/20 Go to details
WHO-4 Argentina Human GISAID : EPI_ISL_430802 0 31/03/20 Go to details

Pre-calculated values are obtained by using ThermonucleotideBLAST (Gans JD, Wolinsky M. 2008), which performs in silico simulations with the NAAT methods stored in our database on the selected high-quality (<1% Ns and <0.05% unique amino acid mutations) and full length (>29,000bp) viral genomes made available by GISAID. The aims are both to detect potential target regions of the NAAT methods and to highlight possible differences with the expected reference sequence which might affect the NAAT performance.

The database contains amplicons collected by screening viral shared genomic sequences of SARSCoV- 2 by in silico determination of PCR-based molecular assays to diagnose COVID-19. The information is retrieved periodically. Acknowledgements

GISAID data provided on this website are subject to GISAID's Terms and Conditions